✦ LIBER ✦

A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a gynecologic oncology group study

✍ Scribed by Peter G Rose; John A Blessing; Harrison G Ball; James Hoffman; David Warshal; Koen DeGeest; David H Moore

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of weekly paclitaxel (80

✍ Maurie Markman; John Blessing; Stephen C. Rubin; Joseph Connor; Parviz Hanjani; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Paclitaxel, carboplatin and pegylated li

✍ Peter G. Rose; Benjamin E. Greer; Ira R. Horowitz; Maurie Markman; Nancy Fusco 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Intraperitoneal Interferon-α in Residual

✍ Jonathan S. Berek; Maurie Markman; Bette Stonebraker; Samuel S. Lentz; Mark D. A 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A Phase II Study of Intraperitoneal Cisp

✍ Lynn G. Feun; John A. Blessing; Francis J. Major; Philip J. DiSaia; Ronald D. Al 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Phase II evaluation of 9-aminocamptothec

✍ David Scott Miller; John A. Blessing; Steven Waggoner; Jeanne Schilder; Joel Sor 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Docetaxel-vinorelbine combination for pl

✍ G. Aravantinos; D. Bafaloukos; M.A. Dimopoulos; C. Nikolaides; P. Papakostas; Ch 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 159 KB